Tucker Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
Tucker Asset Management's AMRX Position: Q3 2026 in Review
Tucker Asset Management reduced its Amneal Pharmaceuticals (AMRX) stake by 49% in Q3 2026, selling an estimated $9.01M and leaving 511,064 shares worth $10.3M. The position accounts for 2.54% of the portfolio, ranked #6.
Tucker Asset Management first reported a position in AMRX in Q2 2024 and has held it in 10 quarters since. The position peaked at $17.5M in Q2 2026. 289 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- Tucker Asset Management held 511,064 shares of Amneal Pharmaceuticals worth $10.3M as of Q3 2026.
- Tucker Asset Management sold 500,000 Amneal Pharmaceuticals shares in Q3 2026, an estimated $9.01M.
- Amneal Pharmaceuticals made up 2.54% of Tucker Asset Management's portfolio in Q3 2026, its #6 holding.
- Tucker Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
- Tucker Asset Management's Amneal Pharmaceuticals position peaked at $17.5M in Q2 2026.
- 289 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on Tucker Asset Management's 13F filing for Q3 2026, filed 29 Oct 2026.